Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation.
Jasmijn A M SleutjesJeanine E Roeters van LennepC Janneke van der WoudeAnnemarie C de VriesPublished in: Inflammatory bowel diseases (2022)
Prednisone and tofacitinib induction therapy significantly increase serum lipid levels, whereas no changes were observed in other drug classes. The observations seem drug-specific inasmuch as adjustment for systemic inflammation did not alter the results.